Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Aerie Pharmaceuticals stock | $13.23

Learn how to easily invest in Aerie Pharmaceuticals stock.

Aerie Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Aerie Pharmaceuticals shares (AERI) are listed on the NASDAQ and all prices are listed in US Dollars. Aerie Pharmaceuticals employs 365 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Aerie Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AERI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Aerie Pharmaceuticals stock price (NASDAQ: AERI)

Use our graph to track the performance of AERI stocks over time.

Aerie Pharmaceuticals shares at a glance

Information last updated 2021-10-16.
Latest market close$13.23
52-week range$9.01 - $21.30
50-day moving average $13.26
200-day moving average $15.63
Wall St. target price$25.45
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.61

Buy Aerie Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aerie Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aerie Pharmaceuticals price performance over time

Historical closes compared with the close of $13.23 from 2021-10-15

1 week (2021-10-06) N/A
1 month (2021-09-17) 2.24%
3 months (2021-07-16) -13.36%
6 months (2021-04-16) -23.30%
1 year (2020-10-16) 13.66%
2 years (2019-10-17) -37.74%
3 years (2018-10-17) 60.04
5 years (2016-10-17) 37.19

Aerie Pharmaceuticals financials

Revenue TTM $94.9 million
Gross profit TTM $55.5 million
Return on assets TTM -22.77%
Return on equity TTM -663.12%
Profit margin -175.35%
Book value $0.51
Market capitalisation $624.9 million

TTM: trailing 12 months

Shorting Aerie Pharmaceuticals shares

There are currently 7.2 million Aerie Pharmaceuticals shares held short by investors – that's known as Aerie Pharmaceuticals's "short interest". This figure is 36% up from 5.3 million last month.

There are a few different ways that this level of interest in shorting Aerie Pharmaceuticals shares can be evaluated.

Aerie Pharmaceuticals's "short interest ratio" (SIR)

Aerie Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Aerie Pharmaceuticals shares currently shorted divided by the average quantity of Aerie Pharmaceuticals shares traded daily (recently around 989059.7260274). Aerie Pharmaceuticals's SIR currently stands at 7.3. In other words for every 100,000 Aerie Pharmaceuticals shares traded daily on the market, roughly 7300 shares are currently held short.

However Aerie Pharmaceuticals's short interest can also be evaluated against the total number of Aerie Pharmaceuticals shares, or, against the total number of tradable Aerie Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aerie Pharmaceuticals's short interest could be expressed as 0.15% of the outstanding shares (for every 100,000 Aerie Pharmaceuticals shares in existence, roughly 150 shares are currently held short) or 0.1658% of the tradable shares (for every 100,000 tradable Aerie Pharmaceuticals shares, roughly 166 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Aerie Pharmaceuticals.

Find out more about how you can short Aerie Pharmaceuticals stock.

Aerie Pharmaceuticals share dividends

We're not expecting Aerie Pharmaceuticals to pay a dividend over the next 12 months.

Aerie Pharmaceuticals share price volatility

Over the last 12 months, Aerie Pharmaceuticals's shares have ranged in value from as little as $9.01 up to $21.3. A popular way to gauge a stock's volatility is its "beta".

AERI.US volatility(beta: 0.94)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aerie Pharmaceuticals's is 0.9444. This would suggest that Aerie Pharmaceuticals's shares are less volatile than average (for this exchange).

Aerie Pharmaceuticals overview

Aerie Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, ocular surface, and retinal diseases in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma. The company is also developing AR-15512 to treat signs and symptoms of dry eye; and AR-1105, AR-13503 SR, and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.

Frequently asked questions

What percentage of Aerie Pharmaceuticals is owned by insiders or institutions?
Currently 2.498% of Aerie Pharmaceuticals shares are held by insiders and 108.612% by institutions.
How many people work for Aerie Pharmaceuticals?
Latest data suggests 365 work at Aerie Pharmaceuticals.
When does the fiscal year end for Aerie Pharmaceuticals?
Aerie Pharmaceuticals's fiscal year ends in December.
Where is Aerie Pharmaceuticals based?
Aerie Pharmaceuticals's address is: 4301 Emperor Boulevard, Durham, NC, United States, 27703
What is Aerie Pharmaceuticals's ISIN number?
Aerie Pharmaceuticals's international securities identification number is: US00771V1089
What is Aerie Pharmaceuticals's CUSIP number?
Aerie Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00771V108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site